PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 8:04 AM ET

Sponsor Check › Person

RM
No photo found yet (own website and image search run after this page is viewed)

Robert More

Named as an officer, director or promoter on SEC Form D filings · NJ, CA, WA, MA, GA · Mar 17, 2010 → Feb 13, 2024

15deals (issuers)
$1.3Breported sold
368investors
33Form D filings
2010–2024years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Robert More is listed as an executive officer and director on 33 SEC Form D filings by 15 issuers between May 2009 and Feb 2024. Largest by amount reported sold: Frazier Healthcare VII, L.P. (Seattle, WA — pooled investment fund — 2012; $293.9M reported sold to 37 investors), Vir Biotechnology, Inc. (San Francisco, CA — biotechnology — 2018–2020; $250M reported sold to 5 investors), Affinivax, Inc. (Cambridge, MA — biotechnology — 2018–2021; $226M reported sold to 27 investors), Tyra Biosciences, Inc. (Carlsbad, CA — biotechnology — 2024; $200M reported sold to 21 investors), Frazier Healthcare VII-A, L.P. (Seattle, WA — pooled investment fund — 2013; $82.5M reported sold to 3 investors) and 10 more (all listed below).

What this means That is a lot of deals — 15 separate companies raised money with this person listed as executive officer and director, over about 15 years. Across those companies the filings report $1.3B sold in total.

Listed alongside Ryan Drant (13 shared filings), Charles M. Hazard, Jr. (5 shared filings), Dan O'Brien (5 shared filings), Deborah Moore (5 shared filings), Gilbert H. Kliman (5 shared filings) and 116 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.

The issuers belong to 4 sponsor groups: Carticept (2 issuers, $16.6M reported sold, 2010–2016), Frazier Healthcare (26 issuers, $2.74B reported sold, 2012–2026), Med Tech Arbitrage (6 issuers, $67.5M reported sold, 2009–2026) and Group linked by Olav B. Bergheim (14 issuers, $144.9M reported sold, 2008–2025).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name, 4 bankruptcy cases matching the name listed in Key records below.

What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 33 public filings for Robert More and found 18 differences, 3 worth asking the sponsor about: Amount sold went down between filings; Robert More is no longer listed on the May 15, 2017 amendment; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Robert More has not run yet — it is #14,030 of 29,783 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

1 case: 1 closed (disposition not in docket feed)

In Re: Robert J. More closed
District Court, N.D. Illinois · No. 1:05-cv-05472 · Filed Sep 23, 2005 · Closed Sep 23, 2005
Role of Robert J. More: Party · Outcome: Terminated 2005-09-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in IL (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Robert More..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

4 cases: 4 closed (disposition not in docket feed)

Robert More closed
United States Bankruptcy Court, W.D. Texas · No. 21-10373 · Filed May 7, 2021 · Closed Aug 13, 2021
Role of Robert More: Debtor · Outcome: Case closed 2021-08-13 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in TX (not a filing state)
ROBERT C MORE closed
United States Bankruptcy Court, D. Arizona · No. 2:20-bk-10417 · Filed Sep 15, 2020 · Closed Jan 5, 2021
Role of ROBERT C MORE: Debtor · Outcome: Case closed 2021-01-05 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in AR (not a filing state)
ROBERT A. MORE closed
United States Bankruptcy Court, D. Nevada · No. 02-51516 · Filed May 9, 2002 · Closed Sep 16, 2002
Role of ROBERT A. MORE: Debtor · Outcome: Case closed 2002-09-16 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in NV (not a filing state)
Robert E. More closed
United States Bankruptcy Court, M.D. Florida · No. 8:88-bk-03809 · Filed Jul 6, 1988 · Closed Jan 14, 1993
Role of Robert E. More: Debtor · Outcome: Case closed 1993-01-14 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 8 federal dockets); court in FL (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

18 differences found between the filings for Robert More — 3 worth asking about (compared 33 filings on Oct 24, 2026)

Note · Dec 2, 1994 – Mar 5, 2021

5 bankruptcy cases name the subject or team members

Bankruptcy case: Seton Medical Center v. Glaukos Corporation — filed Aug 27, 2020 · Bankruptcy case: Filice v. PRP II Pals Investments Trust — filed Aug 9, 2016 · Bankruptcy case: John T Spitznagel — filed Jul 13, 2012 · Bankruptcy case: Filice v. Citifinancial Mortgage, Inc. — filed Apr 15, 2011 · Bankruptcy case: Household Credit Services v. Frueh — filed Dec 2, 1994

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, C.D. California ↗GLAUKOS Corp — PartnerFacts page ↗Docket · United States Bankruptcy Court, E.D. California ↗Becki Filice — PartnerFacts page ↗
Sources
Worth asking · Aug 25, 2009 – Mar 17, 2010

Amount sold went down between filings — NUON THERAPEUTICS INC

The Aug 25, 2009 filing says $13,662,500 sold; the Mar 17, 2010 Form D says $6,053,189 sold — $7,609,311 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Aug 25, 2009 ↗Form D (later) · Mar 17, 2010 ↗NUON THERAPEUTICS INC — PartnerFacts page ↗
Sources
Note · May 27, 2009

Robert More appears on 1 deal that stopped filing before reaching its target

OCEANA THERAPEUTICS, INC. (last filing May 27, 2009; $3,000,000 sold of $50,000,001). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

OCEANA THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Mar 6, 2013 – Mar 22, 2013

Form D filed 16 days after the first sale — Achaogen Inc

The filing says the first sale was Mar 6, 2013. The Form D was filed Mar 22, 2013 — 16 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 1 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Mar 22, 2013 ↗Achaogen Inc — PartnerFacts page ↗
Sources
Note · Dec 29, 2011 – Jan 17, 2012

Form D filed 19 days after the first sale — Carticept Medical Inc

The filing says the first sale was Dec 29, 2011. The Form D was filed Jan 17, 2012 — 19 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 4 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Jan 17, 2012 ↗Carticept Medical Inc — PartnerFacts page ↗
Sources
Note · May 13, 2008 – Jun 29, 2018

17 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Vir Biotechnology, Inc. (latest filing Jun 29, 2018) · No amendment in the last 12 months on an offering that may still be open — Cartiva, Inc. (latest filing Nov 18, 2016) · No amendment in the last 12 months on an offering that may still be open — Cartiva, Inc. (latest filing Apr 17, 2015) · No amendment in the last 12 months on an offering that may still be open — Cartiva, Inc. (latest filing Jul 24, 2013) · No amendment in the last 12 months on an offering that may still be open — Achaogen Inc (latest filing Mar 22, 2013) · and 12 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Jun 29, 2018 ↗Vir Biotechnology, Inc. — PartnerFacts page ↗Form D · Nov 18, 2016 ↗Cartiva, Inc. — PartnerFacts page ↗
Sources
Worth asking · Oct 20, 2015 – May 15, 2017

Robert More is no longer listed on the May 15, 2017 amendment — Sienna Biopharmaceuticals, Inc.

Robert More appears on the Oct 20, 2015 Form D (executive officer, director) but not on the May 15, 2017 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Form D · Oct 20, 2015 ↗Form D/A · May 15, 2017 ↗Robert More — PartnerFacts page ↗Sienna Biopharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Jul 3, 2012 – Sep 30, 2013

Robert More is no longer listed on the Sep 30, 2013 amendment — Frazier Healthcare VII, L.P.

Robert More appears on the Jul 3, 2012 Form D (executive officer) but not on the Sep 30, 2013 Form D/A for the same offering.

What this means People leave, and the issuer must list only current officers, directors and promoters. It is still worth asking why this person left and who replaced them.

Form D · Jul 3, 2012 ↗Form D/A · Sep 30, 2013 ↗Robert More — PartnerFacts page ↗Frazier Healthcare VII, L.P. — PartnerFacts page ↗
Sources
Note · Oct 20, 2015 – May 15, 2017

Offering amount changed between filings — Sienna Biopharmaceuticals, Inc.

The Oct 20, 2015 filing says $40,358,076 offered; the May 15, 2017 Form D/A says $50,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Oct 20, 2015 ↗Form D/A (later) · May 15, 2017 ↗Sienna Biopharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Jun 7, 2011 – Dec 5, 2011

Offering amount changed between filings — Moximed, Inc

The Jun 7, 2011 filing says $45,300,000 offered; the Dec 5, 2011 Form D/A says $45,862,892.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Jun 7, 2011 ↗Form D/A (later) · Dec 5, 2011 ↗Moximed, Inc — PartnerFacts page ↗
Sources
Note · Aug 25, 2009 – Mar 17, 2010

Offering amount lowered between filings — NUON THERAPEUTICS INC

The Aug 25, 2009 filing says $13,662,500 offered; the Mar 17, 2010 Form D says $6,125,766.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Form D (earlier) · Aug 25, 2009 ↗Form D (later) · Mar 17, 2010 ↗NUON THERAPEUTICS INC — PartnerFacts page ↗
Sources
Note · Jul 3, 2012 – Sep 30, 2013

Minimum investment changed between filings — Frazier Healthcare VII, L.P.

The Jul 3, 2012 filing lists a minimum of $1,000,000; the Sep 30, 2013 Form D/A lists $50,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Jul 3, 2012 ↗Form D/A (later) · Sep 30, 2013 ↗Frazier Healthcare VII, L.P. — PartnerFacts page ↗
Sources
Note · Jun 7, 2011 – Dec 5, 2011

Minimum investment changed between filings — Moximed, Inc

The Jun 7, 2011 filing lists a minimum of $2; the Dec 5, 2011 Form D/A lists $1.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Jun 7, 2011 ↗Form D/A (later) · Dec 5, 2011 ↗Moximed, Inc — PartnerFacts page ↗
Sources
Note · May 27, 2009 – Jan 17, 2012

Robert More is written 2 different ways on the filings

listed as "Robert More" on 29 filings (from May 27, 2009), and "Robert J. More" on 4 filings (from Jan 17, 2012).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D/A · May 27, 2009 ↗Form D · Jan 17, 2012 ↗Robert More — PartnerFacts page ↗
Sources
Note · Aug 25, 2009 – Aug 11, 2010

Industry group changed between filings — NUON THERAPEUTICS INC

"Other" (Aug 25, 2009); then "Pharmaceuticals" (Mar 17, 2010); then "Biotechnology" (Aug 11, 2010).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Aug 25, 2009 ↗Form D · Mar 17, 2010 ↗Form D · Aug 11, 2010 ↗NUON THERAPEUTICS INC — PartnerFacts page ↗
Sources
Note · Jan 5, 2018 – Jan 13, 2021

Address moved from North Cambridge, MA to Cambridge, MA — Affinivax, Inc.

The people listed on the Jan 5, 2018 filing give North Cambridge, MA; on the Jan 13, 2021 filing they give Cambridge, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jan 5, 2018 ↗Form D · Jan 13, 2021 ↗Affinivax, Inc. — PartnerFacts page ↗
Sources
Note · Oct 20, 2015 – May 15, 2017

Address moved from Carlsbad, CA to Westlake Village, CA — Sienna Biopharmaceuticals, Inc.

The people listed on the Oct 20, 2015 filing give Carlsbad, CA; on the May 15, 2017 filing they give Westlake Village, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Oct 20, 2015 ↗Form D/A · May 15, 2017 ↗Sienna Biopharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · May 27, 2009 – Feb 13, 2024

Robert More is listed with 5 different address states: NJ, WA, CA, MA, GA

NJ on 1 filing (May 27, 2009); WA on 5 filings (Mar 12, 2010 to May 8, 2013); CA on 17 filings (Mar 17, 2010 to Feb 13, 2024); MA on 7 filings (Sep 26, 2011 to Jan 13, 2021); GA on 3 filings (Jul 24, 2013 to Nov 18, 2016).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D/A · May 27, 2009 ↗Form D · Mar 12, 2010 ↗Form D · Mar 17, 2010 ↗Form D · Sep 26, 2011 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 31 offerings reports sales commissions totalling $232,500; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Feb 13, 2024 D
Tyra Biosciences, Inc.
File 021-505161
$0$0$0None listed on this filingEDGAR ↗
Jan 13, 2021 D
Affinivax, Inc.
File 021-386253
$0$0$0None listed on this filingEDGAR ↗
May 8, 2020 D
Vir Biotechnology, Inc.
File 021-366580
$0$0$0None listed on this filingEDGAR ↗
May 8, 2020 D
Vir Biotechnology, Inc.
File 021-366581
$0$0$0None listed on this filingEDGAR ↗
Jun 29, 2018 D
Vir Biotechnology, Inc.
File 021-315844
$0$0$0None listed on this filingEDGAR ↗
Jan 5, 2018 D
Affinivax, Inc.
File 021-302491
$0$0$0None listed on this filingEDGAR ↗
Nov 18, 2016 D
Cartiva, Inc.
File 021-274816
$0$0$0None listed on this filingEDGAR ↗
Oct 20, 2015 D
Sienna Biopharmaceuticals, Inc.
File 021-249771
$0$0$0None listed on this filingEDGAR ↗
Apr 17, 2015 D
Cartiva, Inc.
File 021-238181
$0$0$0None listed on this filingEDGAR ↗
Jul 24, 2013 D
Cartiva, Inc.
File 021-200199
$0$0$0None listed on this filingEDGAR ↗
May 8, 2013 D
Frazier Healthcare VII-A, L.P.
File 021-196141
$0$0$0 (est.)
The general partner or an affiliate thereof will receive a management fee payable by FH VII.
None listed on this filingEDGAR ↗
Mar 22, 2013 D
Achaogen Inc
File 021-193796
$0$0$0None listed on this filingEDGAR ↗
Jan 25, 2013 D
GLAUKOS Corp
File 021-190823
$0$0$0None listed on this filingEDGAR ↗
Dec 13, 2012 D
PATIENTKEEPER INC
File 021-188300
$232,500$0$0Trump Securities, LLC BrokerCheck CRD 47107 ↗EDGAR ↗
Oct 3, 2012 D
GLAUKOS Corp
File 021-184931
$0$0$0None listed on this filingEDGAR ↗
Aug 10, 2012 D
GLAUKOS Corp
File 021-182573
$0$0$0None listed on this filingEDGAR ↗
Jul 3, 2012 D
Frazier Healthcare VII, L.P.
File 021-180706
$0$0$0 (est.)
An affiliate of the General Partner will receive an investment advisory fee payable by the Issuer quarterly in advance. The investment advisory fee will generally be equal to a percentage of commitments as specified in the Issuer's constituent agreement.
None listed on this filingEDGAR ↗
Jun 21, 2012 D/A
PATIENTKEEPER INC
File 021-180127
$0$0$0None listed on this filingEDGAR ↗
Jan 17, 2012 D
Carticept Medical Inc
File 021-171945
$0$0$0None listed on this filingEDGAR ↗
Dec 22, 2011 D
PATIENTKEEPER INC
File 021-170556
$0$0$0None listed on this filingEDGAR ↗
Dec 5, 2011 D/A
Moximed, Inc
File 021-160894
$0$0$0None listed on this filingEDGAR ↗
Sep 26, 2011 D
PATIENTKEEPER INC
File 021-166341
$0$0$0None listed on this filingEDGAR ↗
Jul 11, 2011 D
PIVOT MEDICAL INC
File 021-162630
$0$0$0
Funds to be used for working capital
None listed on this filingEDGAR ↗
Feb 1, 2011 D
GLAUKOS Corp
File 021-154689
$0$0$0None listed on this filingEDGAR ↗
Dec 21, 2010 D
PIVOT MEDICAL INC
File 021-152280
$0$0$0None listed on this filingEDGAR ↗
Sep 23, 2010 D
GLAUKOS Corp
File 021-148086
$0$0$0None listed on this filingEDGAR ↗
Aug 11, 2010 D
NUON THERAPEUTICS INC
File 021-146233
$0$0$0None listed on this filingEDGAR ↗
Apr 19, 2010 D
Achaogen Inc
File 021-140790
$0$0$0None listed on this filingEDGAR ↗
Mar 17, 2010 D
NUON THERAPEUTICS INC
File 021-117069
$0$0$0None listed on this filingEDGAR ↗
Mar 12, 2010 D
Carticept Medical Inc
File 021-82434
$0$0$0None listed on this filingEDGAR ↗
May 27, 2009 D/A
OCEANA THERAPEUTICS, INC.
File 021-118709
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 15

Every issuer that named Robert More on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

TB
Biotechnology

Tyra Biosciences, Inc.

Carlsbad, CA · Feb 13, 2024
  • Feb 13, 2024 · D · $199,999,934 sold of $199,999,934 · 21 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $200M from 21 investors (100% of the $200M target) as of the latest filing. Robert is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

A
Biotechnology

Affinivax, Inc.

Cambridge, MA · Jan 5, 2018 → Jan 13, 2021 · 2 filings
  • Jan 13, 2021 · D · $225,999,698 sold of $225,999,698 · 27 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 5, 2018 · D · $6,987,455 sold of $6,987,455 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $226M from 27 investors (100% of the $226M target) as of the latest filing. Robert is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VB
Biotechnology

Vir Biotechnology, Inc.

San Francisco, CA · Jun 29, 2018 → May 8, 2020 · 3 filings
  • May 8, 2020 · D · $32,444,441 sold of $32,444,441 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 8, 2020 · D · $250,000,000 sold of $250,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 29, 2018 · D · $66,000,000 sold of Indefinite · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $250M from 5 investors (100% of the $32.4M target) as of the latest filing. Robert is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

C
Other Health Care · group: Carticept

Cartiva, Inc.

Alpharetta, GA · Jul 24, 2013 → Nov 18, 2016 · 3 filings
  • Nov 18, 2016 · D · $7,000,000 sold of $8,500,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 17, 2015 · D · $6,000,001 sold of $8,500,001 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 24, 2013 · D · $4,312,712 sold of $4,482,240 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $7M from 9 investors (82% of the $8.5M target) as of the latest filing. Robert is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SB
Biotechnology

Sienna Biopharmaceuticals, Inc.

Weslake Village, CA · Oct 20, 2015
  • Oct 20, 2015 · D · $18,466,888 sold of $40,358,076 · 12 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $46.6M from 91 investors (100% of the $40.4M target) as of the latest filing. Robert is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

FH
Pooled Investment Fund · group: Frazier Healthcare

Frazier Healthcare VII-A, L.P.

Seattle, WA · May 8, 2013
  • May 8, 2013 · D · $82,500,000 sold of $82,500,000 · 3 investors · min. $1,000,000 · role: Executive Officer (Member of the general partner of the Issuer's general partner) EDGAR ↗

Raised $82.5M from 3 investors (100% of the $82.5M target) as of the latest filing. Robert is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

A
Biotechnology

Achaogen Inc

South San Francisco, CA · Apr 19, 2010 → Mar 22, 2013 · 2 filings
  • Mar 22, 2013 · D · $18,905,707 sold of $30,683,703 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 19, 2010 · D · $35,360,873 sold of $56,413,706 · 15 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $35.4M from 15 investors (100% of the $30.7M target) as of the latest filing. Robert is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

GC
Other Health Care · group: Group linked by Olav B. Bergheim

GLAUKOS Corp

Laguna Hills, CA · Sep 23, 2010 → Jan 25, 2013 · 5 filings
  • Jan 25, 2013 · D · $30,000,002 sold of $30,000,002 · 20 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 3, 2012 · D · $6,000,000 sold of $6,000,000 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 10, 2012 · D · $4,500,000 sold of $4,500,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 1, 2011 · D · $29,500,003 sold of $29,500,003 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 23, 2010 · D · $6,000,392 sold of $6,000,392 · 11 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $30M from 20 investors (100% of the $30M target) as of the latest filing. Robert is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

P
Other Health Care

PATIENTKEEPER INC

Waltham, MA · Sep 26, 2011 → Dec 13, 2012 · 5 filings
  • Dec 13, 2012 · D · $900,000 sold of $1,080,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 21, 2012 · D/A · $1,973,215 sold of $6,250,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 21, 2012 · D · $1,973,215 sold of $6,250,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 22, 2011 · D · $558,653 sold of $3,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 26, 2011 · D · $1,500,000 sold of $3,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $8.28M from 10 investors (100% of the $1.08M target) as of the latest filing. Robert is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

FH
Pooled Investment Fund · group: Frazier Healthcare

Frazier Healthcare VII, L.P.

Seattle, WA · Jul 3, 2012
  • Jul 3, 2012 · D · $0 sold of $400,000,000 · 0 investors · min. $1,000,000 · role: Executive Officer (Member of the general partner of the Issuer's general partner) EDGAR ↗

Raised $293.9M from 37 investors (73% of the $400M target) as of the latest filing. Robert is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

CM
Other Health Care · group: Carticept

Carticept Medical Inc

Alpharetta, GA · Mar 12, 2010 → Jan 17, 2012 · 2 filings
  • Jan 17, 2012 · D · $9,566,312 sold of $10,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 12, 2010 · D · $10,000,001 sold of $20,000,002 · 0 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $10M from 3 investors (100% of the $10M target) as of the latest filing. Robert is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

M
Other Health Care · group: Med Tech Arbitrage

Moximed, Inc

Fremont, CA · Jun 7, 2011 → Dec 5, 2011 · 2 filings
  • Dec 5, 2011 · D/A · $45,837,656 sold of $45,862,892 · 55 investors · min. $1 · role: Director EDGAR ↗
  • Jun 7, 2011 · D · $43,269,656 sold of $45,300,000 · 6 investors · min. $2 · role: Director EDGAR ↗

Raised $62.7M from 104 investors (100% of the $45.9M target) as of the latest filing. Robert is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

PM
Other Health Care

PIVOT MEDICAL INC

Sunnyvale, CA · Dec 21, 2010 → Jul 11, 2011 · 2 filings
  • Jul 11, 2011 · D · $2,000,000 sold of $5,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 21, 2010 · D · $2,725,000 sold of $5,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $32.4M from 10 investors (100% of the $5M target) as of the latest filing. Robert is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

NT
Biotechnology

NUON THERAPEUTICS INC

San Mateo, CA · Mar 17, 2010 → Aug 11, 2010 · 2 filings
  • Aug 11, 2010 · D · $9,999,999 sold of $9,999,999 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 17, 2010 · D · $6,053,189 sold of $6,125,766 · 6 investors · min. $1 · role: Director EDGAR ↗

Raised $13.7M from 9 investors (100% of the $10M target) as of the latest filing. Robert is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

OT
Pharmaceuticals

OCEANA THERAPEUTICS, INC.

Mendham, NJ · May 27, 2009
  • May 27, 2009 · D/A · $3,000,000 sold of $50,000,001 · 4 investors · min. $16,770 · role: Director EDGAR ↗

Raised $3M from 4 investors (6% of the $50M target) as of the latest filing. Robert is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Robert 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

FV
Management entity

FHM VII, L.L.C.

Executive Officer · 2 shared filings (2 issuers)

Listed on the same filings as Robert More. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Ryan Drant

Director · 13 shared filings (5 issuers) · also on 33 other issuers

Ryan Drant is on 38 issuers in total — a repeat sponsor. Their page lists every one.

CH
No photo found yet (own website and image search run after this page is viewed)
Person

Charles M. Hazard, Jr.

Director · 5 shared filings (1 issuer) · also on 23 other issuers

Charles M. Hazard, Jr. is on 24 issuers in total — a repeat sponsor. Their page lists every one.

OB
No photo found yet (own website and image search run after this page is viewed)
Person

Olav B. Bergheim

Director, Executive Officer · 5 shared filings (1 issuer) · also on 13 other issuers

Olav B. Bergheim is on 14 issuers in total — a repeat sponsor. Their page lists every one.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan T. Silverstein

Director · 5 shared filings (1 issuer) · also on 32 other issuers

Jonathan T. Silverstein is on 33 issuers in total — a repeat sponsor. Their page lists every one.

GK
No photo found yet (own website and image search run after this page is viewed)
Person

Gilbert H. Kliman

Director · 5 shared filings (1 issuer) · also on 6 other issuers

Gilbert H. Kliman is on 7 issuers in total — a repeat sponsor. Their page lists every one.

WL
No photo found yet (own website and image search run after this page is viewed)
Person

William Link

Director · 5 shared filings (1 issuer) · also on 28 other issuers

William Link is on 29 issuers in total — a repeat sponsor. Their page lists every one.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Harrison

Executive Officer · 5 shared filings (1 issuer) · also on 4 other issuers

Richard Harrison is on 5 issuers in total — a repeat sponsor. Their page lists every one.

LM
No photo found yet (own website and image search run after this page is viewed)
Person

Larry Miller, MD

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert More. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Merson

Director · 5 shared filings (1 issuer)

Listed on the same filings as Robert More. Their page shows their other deals.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Brient

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Robert More. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Ralph Sabin

Director · 5 shared filings (1 issuer)

Listed on the same filings as Robert More. Their page shows their other deals.

DM
No photo found yet (own website and image search run after this page is viewed)
Person

Deborah Moore

Executive Officer · 5 shared filings (2 issuers)

Listed on the same filings as Robert More. Their page shows their other deals.

PP
No photo found yet (own website and image search run after this page is viewed)
Person

Peter J. Pizzo

Executive Officer · 5 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Robert More. Their page shows their other deals.

TP
No photo found yet (own website and image search run after this page is viewed)
Person

Timothy J. Patrick

Executive Officer, Director · 5 shared filings (2 issuers)

Listed on the same filings as Robert More. Their page shows their other deals.

TB
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas W. Burns

Executive Officer, Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert More. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

James Melanson

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Robert More. Their page shows their other deals.

DB
No photo found yet (own website and image search run after this page is viewed)
Person

Dan O'Brien

Director · 5 shared filings (1 issuer)

Listed on the same filings as Robert More. Their page shows their other deals.

BB
No photo found yet (own website and image search run after this page is viewed)
Person

Barbara D. Boyan

Director · 4 shared filings (2 issuers)

Listed on the same filings as Robert More. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Robert R. Singer

Executive Officer · 4 shared filings (2 issuers)

Listed on the same filings as Robert More. Their page shows their other deals.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Richard B. Knostman

Executive Officer, Director · 4 shared filings (2 issuers)

Listed on the same filings as Robert More. Their page shows their other deals.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Kristina Burow

Director, Executive Officer · 4 shared filings (2 issuers) · also on 30 other issuers

Kristina Burow is on 32 issuers in total — a repeat sponsor. Their page lists every one.

VS
No photo found yet (own website and image search run after this page is viewed)
Person

Vicki Sato

Director · 3 shared filings (1 issuer) · also on 5 other issuers

Vicki Sato is on 6 issuers in total — a repeat sponsor. Their page lists every one.

DT
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel K. Turner

Director · 3 shared filings (1 issuer) · also on 20 other issuers

Daniel K. Turner is on 21 issuers in total — a repeat sponsor. Their page lists every one.

BH
No photo found yet (own website and image search run after this page is viewed)
Person

Brian Halak

Director · 3 shared filings (3 issuers) · also on 15 other issuers

Brian Halak is on 18 issuers in total — a repeat sponsor. Their page lists every one.

GS
No photo found yet (own website and image search run after this page is viewed)
Person

George Scangos

Executive Officer, Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Robert More. Their page shows their other deals.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Rich Hesp

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Robert More. Their page shows their other deals.

DN
No photo found yet (own website and image search run after this page is viewed)
Person

Dipchand Nishar

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Robert More. Their page shows their other deals.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Perez

Director · 3 shared filings (1 issuer)

Listed on the same filings as Robert More. Their page shows their other deals.

HV
No photo found yet (own website and image search run after this page is viewed)
Person

Herbert Virgin

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Robert More. Their page shows their other deals.

HH
No photo found yet (own website and image search run after this page is viewed)
Person

Howard Horn

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Robert More. Their page shows their other deals.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

Jay Parrish

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert More. Their page shows their other deals.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Kamarck

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Robert More. Their page shows their other deals.

RN
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Nelsen

Director · 3 shared filings (1 issuer) · also on 38 other issuers

Robert Nelsen is on 39 issuers in total — a repeat sponsor. Their page lists every one.

KK
No photo found yet (own website and image search run after this page is viewed)
Person

Kim Kamdar

Director · 2 shared filings (1 issuer) · also on 9 other issuers

Kim Kamdar is on 10 issuers in total — a repeat sponsor. Their page lists every one.

NE
No photo found yet (own website and image search run after this page is viewed)
Person

Nathan Every

Executive Officer · 2 shared filings (2 issuers) · also on 27 other issuers

Nathan Every is on 29 issuers in total — a repeat sponsor. Their page lists every one.

NN
No photo found yet (own website and image search run after this page is viewed)
Person

Nader Naini

Executive Officer · 2 shared filings (2 issuers) · also on 27 other issuers

Nader Naini is on 29 issuers in total — a repeat sponsor. Their page lists every one.

RM
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Malley

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert More. Their page shows their other deals.

SR
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Rocklage

Director · 2 shared filings (1 issuer) · also on 17 other issuers

Scott Rocklage is on 18 issuers in total — a repeat sponsor. Their page lists every one.

HP
No photo found yet (own website and image search run after this page is viewed)
Person

Henry A. Plain, Jr.

Director · 2 shared filings (1 issuer) · also on 13 other issuers

Henry A. Plain, Jr. is on 14 issuers in total — a repeat sponsor. Their page lists every one.

The team behind the deals

C
Sponsor group

Carticept

2 issuers · 6 filings · $16.6M reported sold · 2010–2016

One team, 2 deal companies. Robert More is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Robert More.

FH
Sponsor group

Frazier Healthcare

26 issuers · 34 filings · $2.74B reported sold · 2012–2026

One team, 26 deal companies. Robert More is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Robert More.

MT
Sponsor group

Med Tech Arbitrage

6 issuers · 13 filings · $67.5M reported sold · 2009–2026

One team, 6 deal companies. Robert More is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Robert More.

GL
Sponsor group

Group linked by Olav B. Bergheim

14 issuers · 55 filings · $144.9M reported sold · 2008–2025

One team, 14 deal companies. Robert More is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Robert More.

Same business address

49 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 15 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Robert More by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 15 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Robert More is listed on: none on file. No website or social profile named in Tyra Biosciences, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #106,024 of 374,652 in line (1,383 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Carlsbad, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New Jersey state courts — find the court ↗California — find the county court ↗Los Angeles Superior Court case search ↗Washington Courts case search (dw.courts.wa.gov) ↗Massachusetts MassCourts ↗Georgia state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New Jersey Secretary of State business search ↗California Secretary of State business search ↗Washington Secretary of State business search ↗Massachusetts Secretary of State business search ↗Georgia Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Robert More appears on a new Form D, or when a court case or SEC action is matched to them. See plans →